Visteon (VC)
NASDAQConsumer DiscretionaryAuto PartsSnapshot 2026-07-23
Reading VC? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →NASDAQConsumer DiscretionaryAuto PartsSnapshot 2026-07-23
Reading VC? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment is characterized as a durable compounder with a focus on revenue growth and new business wins. The current thesis state is intact, but recent earnings performance has led to a downward price reaction.
The market appears to have priced in a neutral valuation, with VC being seen as cheap compared to its peers. There is a slight expectations gap, indicating that the market may not fully account for potential upside from management's focus on growth.
Fundamentals are likely to show mixed results in the near term, given the recent earnings miss and fluctuating cash flow. However, management's consistent focus on revenue growth and margin improvement could support stability.
The thesis hinges on the performance of sector bellwethers like ORLY, AZO, and HSAI. If these companies continue to perform well, it could provide a favorable backdrop for VC, while any negative guidance from them could pose risks.
Over the next 1 to 3 years, VC's performance will depend on its ability to navigate sector challenges and execute on its growth priorities. Not investment advice.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. On one hand, there is a strong focus on revenue growth and new business wins, supported by positive developments like Micron's backing and an $800 million share buyback program. On the other hand, the latest earnings report showed a miss, which raises concerns about the company's performance.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Earnings results will show if Visteon can meet its full-year guidance after a Q1 miss.
Confirms one read:Q2 sales are over $900 million. Adjusted EBITDA is over $110 million.
Confirms the other:Q2 sales are under $900 million. Adjusted EBITDA is under $100 million.
Why it matters: Sales growth is crucial for Visteon. A decline would indicate weakening demand.
Confirms:Q2 sales grew more than 2% compared to last year.
Disproves:Q2 sales grew less than 2% compared to last year.
Why it matters: Earnings results will show how well Visteon is managing costs and growing revenue.
Confirms one read:Earnings report shows sales grew more than 5% from last year.
Confirms the other:Earnings report shows sales fell compared to last year.
Why it matters: Better EBITDA means Visteon is handling costs well. This is true even with supply chain problems.
Confirms:Adjusted EBITDA is over $120 million in Q2 2026.
Disproves:Adjusted EBITDA falls below $100 million in Q2 2026.
Why it matters: Better margins show good cost control and efficiency. This can make investors more confident.
Confirms:Adjusted EBITDA margin goes above 11% in Q2 2026.
Disproves:Adjusted EBITDA margin stays below 10% in Q2 2026.
Why it matters: Changes in credit terms can change how Visteon manages money and runs its business.
Confirms one read:News of better credit terms or lower interest rates.
Confirms the other:News of worse credit terms or higher interest rates.
Why it matters: Better cash flow helps support future investments. It also aids in capital allocation.
Confirms:Operating cash flow in Q2 exceeds $20 million.
Disproves:Operating cash flow in Q2 is negative or below $10 million.
Why it matters: Positive cash flow shows financial health. It also means the company can invest in growth.
Confirms:Cash flow from operations turns positive, exceeding $10 million in Q2 2026.
Disproves:Cash flow from operations remains negative in Q2 2026.
Why it matters: Improving operating income is crucial. A rise would show progress in managing costs.
Confirms:Operating income increases from $49M in Q1 2026 to above $60M in Q2 2026.
Disproves:Operating income stays below $49M in Q2 2026.
Why it matters: Higher new business wins would show Visteon's growth momentum and market demand strength.
Confirms:New business wins in Q3 exceed $1.5 billion, indicating strong demand.
Disproves:New business wins are below $1 billion. This shows less interest in the market.
Why it matters: A better margin means lower costs and more efficient operations.
Confirms:Adjusted EBITDA margin is over 12.5% in Q3. This shows better operations.
Disproves:Adjusted EBITDA margin is below 11.5%. This shows ongoing cost pressures.
Why it matters: Completion shows good use of capital and a promise to shareholders.
Confirms:The $200 million share repurchase will be done by Q4 2026.
Disproves:The share repurchase is delayed or canceled. This raises concerns about capital use.